Baseline National Institutes of Health Stroke Scale-Adjusted Time Window for Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke [Clinical Sciences]

Conclusions—
The impact of time-to-treatment on favorable outcome varies widely depending on baseline stroke severity. The window for favorable outcome was ≤120 min for moderate strokes. However, time-to-treatment seemed unrelated to functional outcome in mild and severe stroke.

Source: Stroke - March 24, 2014 Category: Neurology Authors: Muchada, M., Rubiera, M., Rodriguez-Luna, D., Pagola, J., Flores, A., Kallas, J., Sanjuan, E., Meler, P., Alvarez-Sabin, J., Ribo, M., Molina, C. A. Tags: Acute Cerebral Infarction, Thrombolysis Clinical Sciences Source Type: research